HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

US Seizes More Contaminated OTC Sanitizers From Mexico, Plus Subpotent Product From China

Executive Summary

FDA also finding subpotent sanitizers made in China, according to warning letters submitted between 26 January and 5 February. Six recently warned firms began providing OTC sanitizers for distribution in the US after FDA in March temporarily loosened manufacturing standards.

You may also be interested in...



Valisure’s Benzene Testing Finds Problems With OTC Sunscreens, Cosmetic Sun Care Products

Independent lab's analysis found benzene levels at “up to three times the conditionally restricted FDA concentration limit of 2 ppm" in 10 Neutrogena sunscreen formulations.

US Consumer Health Recalls: Still Another Glitch For OTC Hand Sanitizers, ED-Spiked Supplements

Kimberly-Clark's recall of nearly 3,000 cases of Foam Skin Cleanser soap incorrectly labeled as Moisturizing Foam Hand Sanitizer is among recent recalls added to FDA records.

First, Methanol Plagued OTC Sanitizers, Now It's Valisure: Recommends Recalls Due To Benzene

FDA should recall dozens of hand sanitizers found to contain benzene, a known human carcinogen, says Valisure, the compounding pharmacy that raised initial alarm about ranitidine in OTC heartburn drugs, leading eventually to withdrawals of the products.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS150997

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel